Hereditary Angioedema — Icatibanto — Takhzyro

Reading time: 9 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Hereditary Angioedema — Icatibanto — Takhzyro

Clinical Summary and Overview

To clearly understand the clinical aspects involved in Hereditary Angioedema This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Hereditary Angioedema — Icatibanto — Takhzyro" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Hereditary Angioedema — Icatibanto — Takhzyro

Understanding Treatment and Therapeutic Options in Hereditary Angioedema

Hereditary angioedema is a rare genetic condition characterized by recurrent episodes of swelling that can affect the skin, mucous membranes, and gastrointestinal tract. Symptoms often manifest in childhood, as reported in cases where patients have experienced episodes since the age of five. Historically, long-term preventive management for some patients included the use of masculinizing androgenic hormones to try to reduce the frequency and intensity of episodes.

However, therapeutic advances in the fields of immunology and allergology have brought new, much more specific and targeted drug alternatives to the pathophysiological mechanism of the disease. Hereditary angioedema is directly related to the dysregulation of pathways involving bradykinin, a potent vasoactive peptide that causes increased vascular permeability and the characteristic swelling.

In this context, two fundamental modern therapeutic approaches stand out:

  • Icatibanto: It is a medication indicated for the acute treatment of hereditary angioedema attacks. It acts as a bradykinin receptor antagonist, blocking its action and promoting relief of cutaneous and mucosal symptoms during an established attack.
  • Takhzyro (Lanadelumab): This is an innovative monoclonal antibody that acts in long-term prevention. The medication works as a kallikrein enzyme blocker, preventing the overproduction of bradykinin at the root of the problem, which significantly reduces the frequency and severity of seizures.

Proper management of hereditary angioedema requires continuous monitoring by a specialist physician to choose the best therapeutic strategy, whether for preventive control or for rescue during acute crises. This content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized assessment with a specialist physician within the scope of the Brazil Without Allergies Project or its care network.

Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema

In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.

💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management

Mast Cell Activation, Histamine, and the Bradykinin Pathway

Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.

Therapeutic Escalation without Overuse of Corticosteroids

International guidelines recommend second-generation (non-sedating) H1 antihistamines at optimized doses under medical supervision as first-line treatment, reserving anti-IgE monoclonal antibodies (such as omalizumab) for refractory chronic cases and avoiding repeated cycles of systemic corticosteroids that cause a rebound effect. The investigation with allergy test and specialized skin assessment allows for the exclusion of hidden triggers and the alignment of strategies such as, when atopy coexists, allergy vaccine.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond PlanBrazil Without Allergies brings the same high standard of care from its clinics to your home, with telemedicine consultations and a more accessible path to immunotherapy. Peaceful skin, free from constant itching and sleep-depriving flare-ups.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Hereditary Angioedema This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... rhinitis treatment When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: